Crossref
Loss of CD20 Expression after Rituximab Therapy for B-Cell Lymphomas: A Review of the Literature
Cancer and Clinical Oncology · 2012
DOI: 10.5539/cco.v1n2p1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer and Clinical Oncology, 2012. Verfasst von Naoki Wada und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wada, N., & Aozasa, K. (2012). Loss of CD20 Expression after Rituximab Therapy for B-Cell Lymphomas: A Review of the Literature. Cancer and Clinical Oncology. https://doi.org/10.5539/cco.v1n2p1
Vancouver
Wada N, Aozasa K. Loss of CD20 Expression after Rituximab Therapy for B-Cell Lymphomas: A Review of the Literature. Cancer and Clinical Oncology. 2012. doi:10.5539/cco.v1n2p1
BibTeX
@article{Wada2012,
author = {Wada, Naoki and Aozasa, Katsuyuki},
title = {Loss of CD20 Expression after Rituximab Therapy for B-Cell Lymphomas: A Review of the Literature},
journal = {Cancer and Clinical Oncology},
year = {2012},
doi = {10.5539/cco.v1n2p1}
}
EUVIMED